Eric Butz

Oct 16, 2024 | stocktitan.net | Ed Calamai |Stanley Roberts |Eric Butz |Kelly Byrnes-Blake

Rhea-AI Impact Rhea-AI Sentiment Context Therapeutics Inc. (Nasdaq: CNTX), a biopharmaceutical company focused on T cell engagers for solid tumors, has announced a poster presentation at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting. The presentation will feature their clinical asset CTIM-76, a Claudin 6 x CD3 bispecific antibody.